← Leaderboards
Nigel R Yarlett
Pace University New York
$1,339,938
Attributed
$1,339,938
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,339,938 · 1
By mechanism
R01$1,339,938 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acyltransferase”
- Ta-Yuan Chang · Dartmouth College$16,102,712
- Robert V Farese · Sloan-Kettering Inst Can Research$15,423,676
- Charles O Rock · St. Jude Children'S Research Hospital$8,820,510
- Henry J. Pownall · Methodist Hospital Research Institute$8,359,229
- Abhimanyu Garg · Ut Southwestern Medical Center$8,308,808
- Mary Jackson · Colorado State University$8,123,498
Research focus
AcyltransferaseAdenosine TriphosphateAmine Oxidase (Copper)AnalogAntimicroorganism AntibodyAntiprotozoal AgentsBiological TransportChemical SynthesisCryptosporidiosisCryptosporidiumCytotoxicityDisease /Disorder ModelDrug Design /Synthesis /ProductionDrug MetabolismDrug Screening /EvaluationEnzyme ActivityEnzyme InhibitorsLaboratory MouseMembrane Transport ProteinsMicroorganism Disease ChemotherapyPolyaminesProtein PurificationTissue /Cell Culture
Grant awards (4)
POLYAMINE METABOLISM OF CRYPTOSPORIDIA:RATIONAL THERAPY$371,436
R01 · FY2004 · AI
POLYAMINE METABOLISM OF CRYPTOSPORIDIA:RATIONAL THERAPY$360,619
R01 · FY2003 · AI
POLYAMINE METABOLISM OF CRYPTOSPORIDIA:RATIONAL THERAPY$308,434
R01 · FY2002 · AI
POLYAMINE METABOLISM OF CRYPTOSPORIDIA:RATIONAL THERAPY$299,449
R01 · FY2001 · AI